These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23934620)

  • 1. Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies?
    Gopal Rao G; Batura D
    Int Urol Nephrol; 2014 Feb; 46(2):309-15. PubMed ID: 23934620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.
    Batura D; Rao GG; Nielsen PB
    BJU Int; 2010 Oct; 106(7):1017-20. PubMed ID: 20346055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates.
    Batura D; Rao GG; Bo Nielsen P; Charlett A
    BJU Int; 2011 Mar; 107(5):760-764. PubMed ID: 21029317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound-guided prostate biopsy.
    Schaeffer AJ
    BJU Int; 2013 May; 111(6):853-4. PubMed ID: 23615027
    [No Abstract]   [Full Text] [Related]  

  • 9. Words of wisdom. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Bartoletti R; Cai T
    Eur Urol; 2015 Mar; 67(3):591-2. PubMed ID: 25760414
    [No Abstract]   [Full Text] [Related]  

  • 10. Infections after transrectal ultrasonic guided prostate biopsies - a retrospective study.
    Danielsen L; Faizi G; Snitgaard S; Lund L; Frey A
    Scand J Urol; 2019; 53(2-3):97-101. PubMed ID: 31070079
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.
    Luong B; Danforth T; Visnjevac O; Suraf M; Duff M; Chevli KK
    Urology; 2015 Mar; 85(3):511-6. PubMed ID: 25596154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin Resistance: A Review of Patients in East London Undergoing Prostate Biopsy.
    Turner B; Pati J; Nargund V; Claxton A; Longstaff V; Sarkar S; Green J
    Urol Nurs; 2016; 36(4):173-82. PubMed ID: 29240328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
    Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
    BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
    Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial.
    Zembower TR; Maxwell KM; Nadler RB; Cashy J; Scheetz MH; Qi C; Schaeffer AJ
    BMC Infect Dis; 2017 Jun; 17(1):401. PubMed ID: 28592230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy.
    Li CK; Tong BCY; You JHS
    Int J Infect Dis; 2016 Feb; 43():7-12. PubMed ID: 26686941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.